Matches in SemOpenAlex for { <https://semopenalex.org/work/W2519271883> ?p ?o ?g. }
- W2519271883 endingPage "3002" @default.
- W2519271883 startingPage "2992" @default.
- W2519271883 abstract "Hepatocellular carcinoma (HCC) is one of the most common malignant tumors worldwide. Chemoresistance occurrence is a major cause of treatment failure in HCC. Currently, extensive research has revealed diverse mechanisms for chemoresistance, but the molecular mechanisms underlying the role of miRNAs in resistance to 5-FU are not confirmed in HCC cells. By quantitative real-time polymerase chain reaction (qRT-PCR) analysis, we found that miR-144 was significantly decreased in HCC cell lines. It has been further demonstrated that miR-144 were significantly down-regulated in Bel-7402/5-FU cells compared with parental Bel-7402 cells by qRT-PCR and western blot. The expression of Nrf2 was reversely correlated to that of miR-144 in HCC cells. Moreover, Enhancement of 5-FU-induced cytotoxicity and apoptosis are resulted from the transfection with miR-144 mimics in Bel-7402/5-FU cells. Mechanically, miR-144 promoted nuclear factor erythroid-2-related factor-2 (Nrf2) mRNA degradation by directly targeting the Nrf2 3'untranslated region (3'UTR). In addition, ectopic expression of miR-144 in Bel-7402/5-FU cells reduced the levels of Nrf2 and inhibited the transcription of Nrf2-dependent HO-1 gene, thus contributing to 5-FU sensibilization. Conversely, re-expression of Nrf2 partly attenuated the chemosensibilization of miR-144. Our study showed that miR-144 serves as a potential chemoresistance-reversal agent in hepatocellular carcinoma cells, which is at least partly due to the down-regulation of Nrf2-dependent antioxidant pathway." @default.
- W2519271883 created "2016-09-23" @default.
- W2519271883 creator A5000824479 @default.
- W2519271883 creator A5025001259 @default.
- W2519271883 creator A5039366205 @default.
- W2519271883 creator A5049320370 @default.
- W2519271883 creator A5069404739 @default.
- W2519271883 creator A5072392376 @default.
- W2519271883 creator A5082365446 @default.
- W2519271883 date "2016-01-01" @default.
- W2519271883 modified "2023-09-23" @default.
- W2519271883 title "miR-144 reverses chemoresistance of hepatocellular carcinoma cell lines by targeting Nrf2-dependent antioxidant pathway." @default.
- W2519271883 cites W1963876988 @default.
- W2519271883 cites W1989726423 @default.
- W2519271883 cites W2000445643 @default.
- W2519271883 cites W2002892549 @default.
- W2519271883 cites W2020919719 @default.
- W2519271883 cites W2040505605 @default.
- W2519271883 cites W2045393563 @default.
- W2519271883 cites W2049936410 @default.
- W2519271883 cites W2073618374 @default.
- W2519271883 cites W2075141288 @default.
- W2519271883 cites W2088911685 @default.
- W2519271883 cites W2089575387 @default.
- W2519271883 cites W2097226863 @default.
- W2519271883 cites W2111163023 @default.
- W2519271883 cites W2116502153 @default.
- W2519271883 cites W2125536613 @default.
- W2519271883 cites W2132018525 @default.
- W2519271883 cites W2156606085 @default.
- W2519271883 cites W2165167356 @default.
- W2519271883 cites W2169332120 @default.
- W2519271883 cites W2230843763 @default.
- W2519271883 cites W258567613 @default.
- W2519271883 cites W2917837889 @default.
- W2519271883 cites W644811534 @default.
- W2519271883 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4969435" @default.
- W2519271883 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/27508019" @default.
- W2519271883 hasPublicationYear "2016" @default.
- W2519271883 type Work @default.
- W2519271883 sameAs 2519271883 @default.
- W2519271883 citedByCount "29" @default.
- W2519271883 countsByYear W25192718832017 @default.
- W2519271883 countsByYear W25192718832018 @default.
- W2519271883 countsByYear W25192718832019 @default.
- W2519271883 countsByYear W25192718832020 @default.
- W2519271883 countsByYear W25192718832021 @default.
- W2519271883 countsByYear W25192718832022 @default.
- W2519271883 crossrefType "journal-article" @default.
- W2519271883 hasAuthorship W2519271883A5000824479 @default.
- W2519271883 hasAuthorship W2519271883A5025001259 @default.
- W2519271883 hasAuthorship W2519271883A5039366205 @default.
- W2519271883 hasAuthorship W2519271883A5049320370 @default.
- W2519271883 hasAuthorship W2519271883A5069404739 @default.
- W2519271883 hasAuthorship W2519271883A5072392376 @default.
- W2519271883 hasAuthorship W2519271883A5082365446 @default.
- W2519271883 hasConcept C104317684 @default.
- W2519271883 hasConcept C105580179 @default.
- W2519271883 hasConcept C127561419 @default.
- W2519271883 hasConcept C145059251 @default.
- W2519271883 hasConcept C153911025 @default.
- W2519271883 hasConcept C185592680 @default.
- W2519271883 hasConcept C190283241 @default.
- W2519271883 hasConcept C2776415932 @default.
- W2519271883 hasConcept C2778019345 @default.
- W2519271883 hasConcept C502942594 @default.
- W2519271883 hasConcept C54009773 @default.
- W2519271883 hasConcept C54355233 @default.
- W2519271883 hasConcept C81885089 @default.
- W2519271883 hasConcept C86803240 @default.
- W2519271883 hasConcept C89604277 @default.
- W2519271883 hasConcept C97037327 @default.
- W2519271883 hasConceptScore W2519271883C104317684 @default.
- W2519271883 hasConceptScore W2519271883C105580179 @default.
- W2519271883 hasConceptScore W2519271883C127561419 @default.
- W2519271883 hasConceptScore W2519271883C145059251 @default.
- W2519271883 hasConceptScore W2519271883C153911025 @default.
- W2519271883 hasConceptScore W2519271883C185592680 @default.
- W2519271883 hasConceptScore W2519271883C190283241 @default.
- W2519271883 hasConceptScore W2519271883C2776415932 @default.
- W2519271883 hasConceptScore W2519271883C2778019345 @default.
- W2519271883 hasConceptScore W2519271883C502942594 @default.
- W2519271883 hasConceptScore W2519271883C54009773 @default.
- W2519271883 hasConceptScore W2519271883C54355233 @default.
- W2519271883 hasConceptScore W2519271883C81885089 @default.
- W2519271883 hasConceptScore W2519271883C86803240 @default.
- W2519271883 hasConceptScore W2519271883C89604277 @default.
- W2519271883 hasConceptScore W2519271883C97037327 @default.
- W2519271883 hasIssue "7" @default.
- W2519271883 hasLocation W25192718831 @default.
- W2519271883 hasOpenAccess W2519271883 @default.
- W2519271883 hasPrimaryLocation W25192718831 @default.
- W2519271883 hasRelatedWork W1976731363 @default.
- W2519271883 hasRelatedWork W2354780887 @default.
- W2519271883 hasRelatedWork W2359858375 @default.
- W2519271883 hasRelatedWork W2360390751 @default.
- W2519271883 hasRelatedWork W2380107697 @default.
- W2519271883 hasRelatedWork W2386905918 @default.